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Abstract
The Saccharomyces cere˝isiae a-mating pheromones are 12 amino acid lipopeptides whose secretion is dependent on the
ABC transporter, Ste6p. The pheromones are synthesized as 36 and 38 amino acid precursors that terminate in a CaaX box
 .C is Cys, a is an aliphatic residue, and X is the C-terminal amino acid . Posttranslational processing of the a-factor
precursors includes at least 5 events. C-terminal processing of the CaaX box includes farnesylation of Cys, removal of the
-aaX residues, and methylation of the cysteine a-carboxyl group. The N-terminal steps involve proteolytic cleavages that
remove the prosequences. In this report, we have investigated the role of posttranslational modification in the generation of
functional a-factor. Wild type, mutant and chimeric forms of a-factor have been expressed in yeast and assessed for their
abilities to serve as sources of functional a-factor. We have found that although modification of the CaaX box is necessary,
it is not sufficient to generate bioactive a-factor. The amino terminal prosequences are also required. Deletion of these
 .sequences reduces intracellular levels of a-factor resulting in sterility. Glutathione-S-transferase GST -a-factor fusions
undergo CaaX box processing and membrane localization, but are not substrates for the N-terminal proteases and fail to
interact with Ste6p. These results suggest that the amino terminal precursor sequences play a direct role in the generation of
functional a-factor.
Keywords: Post-translational modification; Yeast; Peptide secretion; ATP binding cassette transporter; Glutathione-S-transferase
1. Introduction
Proteins and peptides lacking endoplasmic reticu-
lum signal sequences can be secreted via integral
membrane proteins of the ATP binding cassette
 . w xABC transporterrtraffic ATPase superfamily 1–3 .
Members of this family transport diverse substrates
and are found in prokaryotes, fungi, Drosophila,
Xenopus, and mammals. There is significant interest
in this family because a number of ABC transporters
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have been implicated in human disease. Secretion of
the mating pheromone a-factor by the Saccha-
romyces cere˝isiae ABC transporter Ste6p serves as
an excellent model system for studying ABC trans-
w xporter-mediated peptide secretion 4,5 . Yeast a-fac-
tor is encoded by two genes, MFa1 and MFa2,
producing 36 and 38 amino acid propheromones,
w xrespectively 6 . Mature a-factor is a 12 amino acid
prenylated peptide that arises by posttranslational
w xprocessing of the propheromone 7–9 . At least 5
steps are involved. The first 3 occur on the C-termi-
nal CaaX box where C is Cys, a is an aliphatic
w xresidue, and X is the C-terminal amino acid 10,11 .
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The enzymatic steps involved in CaaX box process-
ing of a-factor include prenylation of Cys by farnesyl
protein transferase, proteolytic removal of the -aaX
residues, and methylation of the newly exposed cys-
w xteine a-carboxyl group 8,9,12,13 . At least 2 prote-
olytic events are required for removal of the N-termi-
nal 21 and 23 amino acid prosequences to produce
w xthe 12 amino acid lipopeptides 14 .
The structural determinants of a-factor that are
required for transport by Ste6p are not well defined.
It is known that CaaX box processing is required to
generate functional a-factor, since mutants that are
not prenylated or methylated are sterile and accumu-
late precursor forms of a-factor in the cytoplasm
w x14,15 . Except for the CaaX box, most of the amino
acids of mature a-factor can be changed without
affecting processing or transport, suggesting that
w xSte6p may be a promiscuous peptide transporter 16 .
To investigate the structural features of a-factor re-
quired for processing and transport, wild type, mutant
and chimeric forms of a-factor have been analyzed.
Our results help define the sequence and structural
requirements for the synthesis and secretion of a-fac-
tor. This study has implications for the use of a-factor
as a signal for secretion of heterologous proteins by
Ste6p.
2. Materials and methods
2.1. Materials
Restriction enzymes and T4 DNA Ligase were
purchased from New England Biolabs and used ac-
cording to the manufacturers instructions. Yeast me-
dia was purchased from Difco. Glutathione agarose
beads and other reagents were purchased from Sigma
unless specified. Sequenase was purchased from
United States Biochemical. Western blots were visu-
 .alized by the Enhanced Chemiluminescence ECL
system purchased from Amersham. Film for auto-
radiography was purchased from Kodak.
2.2. Strains and media
Yeast strains used in these experiments are listed
in Table 1. RJY856 was generated by selecting uracil
w xauxotrophs of yRP713 17 using 5-fluoro-orotic acid
 . w xFOA selection 18 . RJY856 has a uracil prototro-
phy reversion rate of -5=10y6. The sec1-1 and
ste6::HIS3 alleles of strain RJY596 were obtained by
backcrossing lab strains with HMSF-1 and JPY201
w xrespectively 5,19 . Yeast transformations were per-
formed by the lithium acetaterpolyethylene glycol
w xmethod 20 . Unless otherwise stated, cultures were
grown on YEP medium supplemented with 2% glu-
 .  .cose wrv or 4% galactose wrv . Strains harboring
 .plasmids were grown on synthetic medium SC con-
 .taining either 2% glucose wrv or 4% galactose
 . w xwrv 21 .
2.3. Construction of plasmids
A diagram of the plasmid constructs used in this
study is shown in Fig. 1. All constructs are derived
 .from pEG KT and therefore utilize identical promot-
X  .ers, 3 -untranslated regions UTR , and initiator me-
w xthionine residues 22 . Constructs were made using
Table 1
Yeast strains used in this study
Strain Genotype
ayRP713 MATa ura3-52, trp1- D1, rpb1-1, his3- D200,
mfa1::LEU2, mfa2::URA3
bRJY856 MATa ura3-52, trp1- D1, rpb1-1, his3- D200,
mfa1::LEU2, mfa2::ura3
cJPY201 MATa ste6::HIS3
dHMSF-1 sec1-1
eRJY596 MATa leu2 ura3-52, his3- D200, trp1-1, lys2, ade8,
sec1-1, ste6::HIS3
RJY1146 RJY596qpGQ455
RJY1144 RJY596qpGQ455qpGQ292
RJY1145 RJY596qpGQ455qpGQ365
fRJY967 MATa leu2, ura3-52, his3- D200, trp1-1, lys2, ade8,
sec1-1, ste6::HIS3 mfa1::LEU2, mfa2::ura3
RJY853 MATa leu2, ura3, lys2, ade8, trp1
RXBH8-2c MATa sst2-4, Cry1 , his6, ura1
gRJY1136 MATa sst2-4
RJY2 MATa his1
a w x17 .
b w xFrom yRP713 by selection on 5-FOA 18 .
c w x5 .
d w x19 .
e Obtained by crossing the ste6::HIS3 and sec1-1 alleles into RJD
lab strains.
f By crossing RJY856 and RJY596 to RJD lab strains.
g w xDerived by crossing the sst2-4 allele of XBH8-2C 53 into an
RJD lab strain.
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either standard ligation methods with transformation
into bacterial host MC1066 or by a recombination
strategy with transformation directly into a yeast host
w x23 . All constructs were confirmed by sequence anal-
ysis. pGQ292 was made by ligating a 0.97 kb MFa1
PCR product into the polylinker cloning site of
 . w xpEG KT 22 . The CaaX box Cys“Ser mutant,
pGQ365, was made by PCR-mediated mutagenesis
using pGQ292 as a template. To make constructs
expressing a-factor without GST, an in frame dele-
tion was created by cutting pGQ292, pGQ439, and
pGQ508 with BamHI and EcoICRI, converting the
BamHI to a blunt end with Klenow fragment of DNA
polymerase and religating to generate pGQ454,
pGQ453, and pGQ509, respectively. A PCR strategy
was employed to generate fusions with the pro-se-
quences of a-factor preceding GST using upstream
and downstream primers having extensions homolo-
Fig. 1. Schematic diagram of the protein coding regions of a-factor expression plasmids used in this study. The box labeled 12 represents
 .the region encoding the amino acids of mature a-factor YIIKGVFWDPAC and box labeled 3 refers to the VIA sequence of the CaaX
 .box. The pro region represents the amino terminal sequence of the MFa1 precursor peptide MQPSTATAAPKEKTSSEKKDN . The
 .stippled box in the pEG KT construct is a C-terminal 17 amino acid extension that follows GST prior to encountering a stop codon in the
X X w xsequence. All constructs share identical promoters, 3 - and 5 -untranslated regions, and translation initiator methionines 22 .
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gous to the 3X region of CYC1 and the N-terminus of
GST, respectively. These PCR fragments encompass-
ing the precursor sequences were prepared and re-
combined with pGQ439, pGQ508 and pGQ292 to
give pGQ458, pGQ510 and pGQ459, respectively.
Likewise, PCR generated fragments encompassing
the entire pro-a-factor sequence were prepared and
recombined with pGQ292 and pGQ365 to give
pGQ527 and pGQ528, respectively. pGQ455 and
pGQ456 consist of the BamHIrSalI STE6 fragment
w x w x5 inserted into pRS314 and pRS424 24 , respec-
tively. These STE6 constructs also contain an in-frame
c-myc epitope within the putative first extracellular
w xloop 25 .
Mating assays. Patch mating assays were done by
growing cells on SC-Uracilr2% glucose plates for
2–3 days at 308C followed by induction 1–2 days on
SC-Uracilr4% galactose plates. Mating was then
assessed by transferring patches to synthetic minimal
 .plates SD-min containing 4% galactose plates onto
 .which a lawn of either wild type RJY2 or supersen-
 .  . w xsitive sst2 MATa cells XBH8-2C 26 was placed.
Plates were incubated 1–3 days at 308C.
Quantitative liquid mating assays were performed
w xby the method of Jackson and Hartwell 27,28 with
the following modifications. Cells were grown to
mid-log on SC-Uracilr4% galactose and aliquots of
 6.  7.MATa 6=10 and MATa cells 6=10 were
mixed together and collected by centrifugation 500
.=g; 1 min . Cells were washed with 0.4 ml YEP
galactose medium and collected by centrifugation
 .500=g; 1 min . Following 2 h incubation at 308C,
the YEP galactose medium was removed, the cells
were then resuspended in 1 ml synthetic medium and
aliquots of cells were spread on SD-min plates.
Diploids were counted following incubation at 308C
for 2–3 days. Quantitation of a-factor was done by
extracting cell lysates or culture media with n-butanol
w x29 . The n-butanol extract was dried and resus-
 .pended in methanol 100 ml . Aliquots of the
methanol solution were spotted on a lawn of sst2
 . w xMATa XBH8-2C cells 26 .
2.4. Preparation of yeast extracts and immunoblot
analysis
 7Cells were grown to mid-log phase 1=10 rml to
7 .  .2=10 rml on SC-ura galactose 50 ml medium at
308C. The cells were collected by centrifugation
 . 2000=g, 5 min , washed with sorbitol buffer 0.3
M sorbitol, 0.1 M NaCl, 5 mM MgCl , and 10 mM2
.Tris-HCl, pH 7.4 , and resuspended in a final volume
of 0.4 ml sorbitol buffer containing protease in-
hibitors 1 mM PMSF, 100 Urml aprotinin, 100 mM
leupeptin, 1 mM pepstatin A, and 1 mgrml chymo-
. statin . Glass beads 0.2 g, 425–600 mm, Sigma, St.
.Louis, MO, USA were added and cells were lysed
by alternating 1-min intervals of vortexing with 3-min
intervals on ice. Cellular debris and unbroken cells
 .were removed by centrifugation 10 000=g, 5 min .
The supernatant was subjected to centrifugation
 .100 000=g, 1 h at 48C to separate the soluble
 .  .S100 from the membrane bound protein P100 .
The P100 was resuspended in sorbitol buffer with
protease inhibitors. Protein concentrations were deter-
w xmined by Bradford assay 30 .
Approx. 50 mg of the S100 and P100 protein
 .fractions were resolved by SDS-PAGE 12.5% gel
and the proteins were transferred to nitrocellulose at
48C using transfer buffer 20 mM Tris base, 150 mM
 . .glycine, 0.1% SDS and 20% vrv methanol, pH 8.0
at 200 mA for 10 h. All subsequent manipulations
were performed at room temperature. The filter was
 . blocked for 2 h in Tris buffered saline TBS 100
.mM Tris-HCl, pH 7.4, 150 mM NaCl containing
 .0.05% Tween-20 and 5% wrv powdered milk,
washed briefly in TBS and incubated for 1 h with
 .rabbit anti-GST Molecular Probes diluted 1:1000 in
TBS containing 5% milk. After washing 3 times for
10 min with gentle shaking in TBS containing 0.1%
Tween-20, the filter was incubated for 40 min with
Horseradish peroxidase-conjugated protein A
 .Amersham diluted 1:2000 in TBS containing 5%
milk. The filter was washed 5 times for 10 min in
TBS containing 0.1% Tween-20, developed using the
 .ECL detection kit Amersham and exposed to film
 .Kodak X-OMAT for the indicated time.
2.5. Vapor-phase equilibrium assay for methyl esters
Methylation was determined by the method of
w xClarke et al. 31 . RJY1144 and RJY1145 were grown
in synthetic medium lacking tryptophan and uracil
 .  7 .25 ml culture to mid-log phase 2=10 cellsrml
with 2% raffinose as the carbon source non-inducing
.conditions . Galactose was added to a final concentra-
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tion of 4% for 30 min to induce fusion protein
expression. The cells were spun, washed once with
synthetic medium lacking methionine and resus-
pended in 2 ml SC-Met medium containing 4%
3  .galactose and 200 mCi H-AdoMet 87 Cirmmol
 .Amersham . Cells were incubated for 4 h and lysed
using glass beads as described above. GST-a-factor
fusion protein was purified using glutathione agarose
w xbeads followed by SDS-PAGE 22 . The gel was
stained with Coomassie blue and dried onto a piece
of Whatman 3MM paper. The band corresponding to
the GST fusion protein was excised and subjected to
the vapor-phase equilibrium assay to detect base-la-
3 w xbile H-methyl esters 31 .
2.6. Immunofluorescence microscopy
RJY596 cells transformed with the indicated plas-
mids were prepared for immunofluorescence by pre-
w x  7.viously described methods 32 . Cells 2=10 were
permeabilized by resuspending in 1 ml phosphate
buffered sorbitol with 5 ml 2-mercaptoethanol and 30
 . ml Zymolyase 10 mgrml in water 30 min at
.  .308C . Permeabilized cells 15 ml were attached to
 .polylysine Sigma coated immunofluorescence glass
 .slides 10 well, Teflon coated, Polysciences and
allowed to adhere for 2–3 min. Unattached cells were
removed by aspiration and the slides were then sub-
 .merged in ice-cold methanol y208C, 6 min fol-
 .lowed by acetone y208C, 30 s . Slides were air
dried for 10 min at room temperature. Primary anti-
body solutions consisting of either 10 ml of anti-GST
 Molecular Probes, diluted 1:4000 with PBS-BSA 10
.. mgrml or 10 ml of anti-c-myc monoclonal 9E10,
.diluted 1:100 in PBS-BSA were added and the slide
was incubated 2 h at 238C. The primary antibody
solutions were then removed by aspiration and the
wells were washed 5 times with 20 ml PBS-BSA.
Depending on the experiment, the secondary antibod-
ies used were either FITC-conjugated goat anti-rabbit
 .Cappel, 1:4000 with PBS-BSA or Texas Red-con-
jugated goat anti-mouse Cappel, 1:2000 in PBS-
.BSA . Following a 2-h incubation at 238C, the wells
were washed 5 times with 20 ml PBS-BSA. Cells
were visualized using either a Zeiss Axioscope-20 or
a BioRad MRC-600 confocal microscope Central
.Electron Microscopy Facility, University of Iowa .
3. Results
3.1. Expression of the entire a-factor precursor is
required for efficient production of extracellular a-
factor
To determine what role, if any, the amino terminal
prosequences of a-factor play in the synthesis and
 .secretion of the mature peptide, a plasmid pGQ453
was constructed that expresses only the C-terminal 15
amino acids of the MFa1 gene 12 amino acids of
mature a-factor and the C-terminal 3 amino acids of
.the CaaX box from a strong galactose-inducible
w xpromoter present on pEMBLyexT7 33 . A control
plasmid consisting of the entire a-factor 36mer,
.pGQ454 gene in the same plasmid was also pre-
pared. In addition, the CaaX box Cys was mutated to
 .a Ser SaaX box in pGQ453 to create pGQ509
allowing us to assess the role of CaaX processing in
 .a-factor synthesis Fig. 1 . When strains expressing
these plasmids were examined by a sensitive mating
assay, only yeast expressing the complete MFa1 gene
 .were able to mate Fig. 2 .
To determine whether the lack of mating in strains
expressing only the 15 amino acid form of a-factor is
due to failure to synthesize stable peptide or failure to
Fig. 2. Plate mating assay of strain RJY856 expressing either the
 .C-terminal 15 amino acids of pro-a-factor pGQ453 , the parent
  ..  .plasmid pEG KT , or full-length pro-a-factor pGQ454 . Panel
w xA: Growth on synthetic medium plates 21 , lacking uracil and
 . supplemented with 4% galactose wrv SC-uracil, 4% galac-
.  .tose . Panel B: Patches transferred to minimal medium SDmin
 .plates containing 4% galactose and a MATa tester lawn RJY2 .
In Panel B, growth indicates the formation of diploids by mating.
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Fig. 3. Determination of the intracellular levels of mature a-factor. Strain RJY856 expressing either the C-terminal 15 amino acids of
 .   ..  .pro-a-factor pGQ453 , the parent plasmid pEG KT , or full-length pro-a-factor pGQ454 , was grown to mid-log on SC-uracil medium
 .  .4% galactose . Extraction of a-factor was performed as described in Section 2. Lysates were extracted with n-butanol 2 volumes and
 .  .the organic phase dried under vacuum in a Speed-Vac. Pellets were resuspended in methanol 100 ml and aliquots 2 ml were spotted
 .  .onto plates containing a lawn of supersensitive sst2 MATa cells RJY1136 .
secrete it once it is made, levels of intracellular
a-factor were measured. Bioactive a-factor was ex-
tracted from cell lysates of strains expressing either
 .pro-a-factor pGQ454 or the C-terminal 15mer
 .  .pGQ453 Fig. 3 . Although a-factor is easily de-
tected in extracts of strains expressing pro-a-factor,
the levels of a-factor in strains expressing only the
C-terminal 15 amino acids were barely detectable
 .Fig. 3 . Using a serial dilution method, we estimate
that the concentration of a-factor extracted from the
strain expressing only the 15 amino acid form was
500-fold lower than from the same strain expressing
 .full length pro-a-factor data not shown . The a-fac-
tor prosequence is therefore necessary to achieve
 .Fig. 4. Immunoblot analysis of GST-a-factor fusion proteins. RJY596 cells harboring pGQ456 see Section 2 and the indicated GST
 7 7 .  .expression plasmid were grown to mid-log phase 1=10 rml to 2=10 rml on SC-ura-trp, 4% galactose 50 ml medium at 308C.
 .  .Soluble S100 and membrane P100 fractions were prepared and the immunoblot was performed as described in Section 2.
 .  .  .Approximately 50 mg of S100 s or P100 p protein extract were loaded from strain RJY596 expressing either pEG KT , pGQ439,
pGQ508, pGQ292, pGQ365, pGQ458, pGQ510, pGQ527, or pGQ528. Refer to Fig. 1 for the identification of the GST-a-factor fusion
 .  .constructs. The migration position of prestained molecular weight markers Amersham carbonic anhydrase 30 kDa and trypsin inhibitor
 .21 kDa is indicated on the left.
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high steady state levels of intracellular mature a-fac-
tor.
In light of this, a second approach was taken to
express a-factor and investigate the function of the
prosequences. Plasmids were constructed to express
 .a-factor in several forms as GST- pro -a-factor fu-
 .sion proteins Fig. 1 . We considered three potential
outcomes when these fusion proteins were expressed
in yeast. First, the fusion proteins might be exported
intact by Ste6p in a manner similar to that of ABC
w xtransporters whose substrates are large proteins 34 .
Second, complete processing of the a-factor portions
of the fusion proteins could result in secretion of
mature a-factor. Third, the fusion proteins might
interact with the a-factor pathway in an inhibitory
manner, e.g. by competing for sites on Ste6p thereby
blocking endogenous a-factor transport.
3.2. Expression and posttranslational modification of
( )GST- pro -a-factor fusion proteins
To assess interactions of GST-a-factor fusion pro-
teins with the a-factor pathway, we first determined
their levels of expression and whether they are farne-
sylated at the CaaX box. Steady-state levels of GST-
a-factor fusion proteins were measured by im-
 .munoblot and found to be very similar Fig. 4 . We
estimate that the fusion proteins are 2–5% of the total
y y  .Fig. 5. GST-a-factor fusions do not correct the mating defect of an mfa1 , mfa2 strain RJY967 . Panel A: Plasmid key. In addition to
 .the GST-a-factor expression plasmids, all patches are expressing Ste6p from pGQ455, except for the patch designated ste6D which is
harboring the control plasmid pRS314. Panel B: Growth of RJY967 harboring both GST-a-factor on SC-uracil-tryptophan, 4% galactose
plates. Panel C: Diploid formation assessed by the ability to grow on SD min plates containing 4% galactose and a lawn of supersensitive
 .MATa cells XBH8-2c .
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Table 2
Mating efficiencies of MATa strains expressing GST-a-factor
fusion proteins
aStrain Plasmid Mating efficiency
y7 .RJY856 pEG KT -1.0=10
y7pGQ453 -1.0=10
y3pGQ454 3.5=10
y7pGQ292 -1.0=10
y7pGQ459 -1.0=10
y3 .RJY1146 pEG KT 140.0=10
y3pGQ439 27.0=10
y3pGQ508 130.0=10
y3pGQ292 4.6=10
y3pGQ365 120.0=10
y3pEGCT5 17.0=10
a Mating assays were done by the method described by Jackson
w xand Hartwell 27,28 .
 .cellular protein data not shown . Fig. 4 also shows
that GST-a-factor fusions terminating in a SaaX box
 .localize predominantly in soluble S100 fraction,
while wild type CaaX box fusions localize to the
 .membrane fraction P100 . This indicates that the
CaaX box fusion proteins are farnesylated, as farne-
sylation is correlated with membrane localization.
However, N-terminal cleavage does not occur Fig.
.4 . If the correct cleavage had occurred, a slightly
faster migrating form of GST would have appeared in
the S100 fraction of the wild type CaaX box con-
structs. N-terminal proteolysis of a-factor has been
w xshown to require prenylation 15 . Therefore, the low
level of proteolysis observed in the soluble fraction
of the CaaX box mutated fusions GST-a-
 ..factor SaaX is most likely nonspecific proteolysis.
( )3.3. GST- pro -a-factor fusion proteins fail to com-
plement the mating defect of mfa1, mfa2 strains
We used mating assays as a highly sensitive method
to test whether the GST-a-factor fusion proteins could
serve as a source of mature a-factor and therefore
complement the sterility of an mfa1D mfa2D MATa
strain. As seen in Fig. 5, only expression of wild type
pro-a-factor was able to support mating to the super-
 .sensitive tester lawn XBH8-2c: MATa sst2-4 . Fu-
sion of GST anywhere within the a-factor gene inter-
fered with the generation of functional a-factor. Simi-
lar results were obtained using a quantitative mating
assay. Furthermore, none of the GST-a-factor expres-
w3 x w xFig. 6. Base-labile H -methyl ester incorporation assay. Methylation was determined by the method of Clarke et al. 31 . RJY1144 and
 .  7 .RJY1145 were grown in synthetic medium lacking tryptophan and uracil 25 ml culture to mid-log phase 2=10 cellsrml with 2%
 .raffinose as the carbon source non-inducing conditions . Panel A. GST-a-factor fusion proteins were purified from extracts of RJY1145
 .  .grown under galactose-inducing conditions lane 2 , RJY1144 grown under glucose-repressing lane 3 , or RJY1144 grown under
 .  .galactose-inducing conditions lane 4 . Prestained molecular weight markers Amersham were loaded in lane 1. Panel B. Gel slices
corresponding to the GST-a-factor fusions shown in Panel A were excised and subjected to the vapor-phase equilibrium assay to detect
3 w xbase-labile H-methyl esters 31 .
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sion plasmids complemented the mating defect, with
mating efficiencies similar to that of cells harboring
  ..  .the parental plasmid pEG KT data not shown .
This provides further evidence that the GST-a-factor
fusions are not substrates for the N-terminal proteases
and proteolytic cleavage is required for production of
functional mating pheromone. Formally, the mating
defect could arise from a failure to export GST-a-fac-
tor or an inability of the exported fusion protein to
bind and activate the a-factor receptor, Ste3p. How-
ever, very low levels of the GST-a-factor fusion were
detected in extracellular extracts and the amount de-
 .tected was not dependent on STE6 data not shown .
The low levels of GST-a-factor in the medium most
likely arises from cell lysis.
( )3.4. CaaX box methylation of GST- pro -a-factor fu-
sion proteins
Since carboxyl methylation is required for a-factor
w xsecretion by Ste6p 14 , we examined whether the
GST-a-factor fusion proteins were methylated. Strains
 .expressing either wild type CaaX box or mutant
 .SaaX box GST-pro-a-factor fusion proteins were
w3 xincubated with H -AdoMet and base-labile methyla-
tion was measured as described in Section 2. Fig. 6
shows that methyl ester incorporation into wild type
 .CaaX box fusion proteins is approximately 70-fold
increased over the level of background incorporation
 .  .SaaX box . This confirms that the GST- pro -a-fac-
tor fusion proteins are a-carboxyl methylated at the
CaaX box.
( )3.5. Effect of GST- pro -a-factor o˝erexpression on
the synthesis and secretion of endogenous a-factor
We next examined whether overexpression of the
GST-a-factor fusion proteins interferes with process-
ing andror secretion of endogenous a-factor. Al-
though a 30 fold decrease in mating efficiency was
 .observed when GST- pro -a-factor was overex-
pressed in an otherwise wild type cell, it should be
noted that this is a relatively modest inhibition com-
pared to the 106-fold decrease in mating observed
when the a-factor encoding genes are deleted Table
.2 . Overexpression of another GST-CaaX box fusion
protein, derived from the C-terminus of yeast Ras2p,
resulted in a similar decrease in mating efficiency
 .pEGCT5 . In both cases, mutating the CaaX box
Cys to Ser abolished the inhibition pGQ508,
.pGQ365 , indicating that prenylation is required for
inhibition. Taken together, inhibition is most likely
due to a competition with a very early step in a-factor
processing shared with all prenylated proteins CaaX
.box posttranslational modification and not via inhibi-
tion of an a-factor-specific step such as N-terminal
proteolysis or binding to Ste6p. A decrease in cell
viability was also observed in strains expressing high
levels of CaaX box fusion proteins, which might
have also contributed to the decrease in mating effi-
 .ciency data not shown .
Fig. 7. Confocal immunolocalization of strain RJY596 expressing
 .  .Ste6p red and GST fusion proteins green . Myc-epitope-tagged
 .Ste6p expressed from pGQ456 was visualized using mono-
 .clonal antibody 9E10 Panels A and B . Wild type GST-a-factor
 .  .pGQ439, Panel A , mutant GST-a-factor pGQ508, Panel C ,
 .and GST-Ras2 Panel B were visualized using anti-GST anti-
 .body Molecular Probes . Colocalization appears yellow. The
scale bar represents 25 mm. Cells were visualized using a BioRad
MRC-600 confocal microscope Central Electron Microscopy
.Facility, Univ. of Iowa .
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( )3.6. Subcellular localization of GST- pro -a-factor
fusion proteins
Confocal immunofluorescence microscopy was
used to compare the subcellular distribution of GST-
 .a-factor and Ste6p Fig. 7 . Consistent with observa-
w xtions of others 25,35 , Ste6p shows punctate staining
 .within the cytoplasm red , with more intense stain-
 .ing subtending the plasma membrane Fig. 7A,B .
This pattern is clearly distinct from the plasma mem-
brane staining illustrated by the localization of GST-
 .  .Ras2 Fig. 7B . Wild type GST-a-factor green also
appears to be membrane localized, but does not
localize to the plasma membrane or colocalize with
Ste6p, and instead shows perinuclear localization Fig.
.7A . Membrane localization is dependent on CaaX
box processing, since the CaaX to SaaX mutation
results in a diffuse staining pattern consistent with
 .cytoplasmic localization Fig. 7C . A processed CaaX
box is therefore sufficient to target GST-a-factor to a
membrane surface, but the presence of GST prevents
N-terminal proteolysis and colocalization with Ste6p.
Multiple localization signals have been shown to be
required for the proper targeting of other CaaX pro-
w xteins such as Ras 36,37 .
4. Discussion
The steps required for biosynthesis and export of
yeast a-factor have been examined by expressing
different forms of a-factor and by creating fusions
between a-factor and GST. Previous work established
that the CaaX box is necessary for the synthesis and
w xexport of a-factor 14–16 , but here we show that the
CaaX box is not sufficient for the generation of
a-factor competent for export. The amino terminal
prosequence also appears to play an important role in
the biosynthesis of a-factor. If the prosequence is
deleted, the level of detectable a-factor is dramati-
cally reduced resulting in sterility. Two potential
functions for the prosequence can be considered. One
is that it serves to stabilize a-factor by protecting it
from proteolytic degradation. Another is that it plays
an active role in delivering the a-factor precursor
through a transport pathway that culminates in export
by Ste6p. These two models are not mutually exclu-
sive. For example, improperly targeted a-factor may
w xbe more susceptible to degradation 14 . To address
the role of the prosequences we created a series of
fusion proteins between GST and a-factor. A similar
approach has been taken using dihydrofolate reduc-
 .  .tase DHFR -a-factor and interleukin 1 IL1-a-factor
w xfusion proteins 38–40 . In the case of DHFR-a-fac-
tor, the production of insoluble aggregates made it
difficult to determine to what extent normal a-factor
 .processing had occurred. The GST- pro -a-factor fu-
sions we describe are expressed as soluble precursors,
undergo efficient CaaX box processing and become
membrane localized.
None of the GST-a-factor fusions examined were
transported by Ste6p. One reason could be that Ste6p
has a size restriction that is exceeded by the addition
of GST. However, size is unlikely to be the reason
because GST-a-factor fusions do not block transport
of endogenous a-factor and the fusion proteins do not
colocalize with Ste6p. This suggests that GST blocks
a-factor access to the Ste6 export pathway at an
earlier step. Although the exact point of the block has
not been defined, our results rule out several trivial
explanations for how GST interferes with a-factor
function. For example, aggregation or misfolding is
 .unlikely to be the cause because 1 the GST-a-factor
fusion proteins are initially made a soluble precursors
in the cytosolic fraction suggesting that proper fold-
 .ing occurred, 2 both the C- and N-termini of GST,
where a-factor sequences were added, reside on the
surface of the folded protein allowing access to pro-
w x  .cessing enzymes 41 , 3 the a-factor CaaX box is
processed normally in the GST-a-factor fusion pro-
teins. The only difference we detect between GST-a-
factor and endogenous a-factor processing is in the
N-terminal protease steps. Based on these observa-
tions, we propose that the a-factor processing path-
 .way is separated into early CaaX box processing
 .and late events N-terminal proteolysis and transport .
The CaaX box processing steps are shared with other
proteins terminating in CaaX, whereas the late steps
are unique to a-factor. GST only interferes with the
downstream events. This also explains why other
CaaX box proteins such as Ras do not inhibit a-fac-
tor secretion.
Although the mechanism by which prenylated pro-
teins are correctly localized is not well understood, it
has been suggested that at least two signals are
required. Prenylation constitutes the first signal and
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results in non-specific membrane localization. A sec-
ond signal is required to target the prenylated protein
to its final destination. In the case of Ras, palmitoyla-
tion or a stretch of basic amino acid residues serves
as the second signal for localization to the inner
w xsurface of the plasma membrane 36 . Immunolocal-
ization of the GST-a-factor fusion proteins revealed a
perinuclear and particulate staining pattern consistent
with that described for the endoplasmic reticulum in
w xyeast 42,43 . This localization pattern was similar to
that of prenylated, but not palmitoylated Ras2p De-
.schenes, unpublished results , suggesting the first of
the two localization signals, namely CaaX box pro-
cessing, was functioning properly. The failure of the
GST-a-factor fusions to colocalize with Ste6p indi-
cates that N-terminal processing may constitute the
second signal required for targeting pro-a-factor to
 .Ste6p for transport. Recently, a gene AXL1 for one
of the a-factor amino terminal proteases has been
w xreported 44,45 . Loss of function mutations in AXL1
result in a defect in a-factor processing and transport.
The presence of GST could block a-factor cleavage
by Axl1p directly by interfering with cleavage site
recognition, or indirectly, by preventing pro-a-factor
from reaching the subcellular site of action of Axl1p.
The subcellular location of Axl1p is currently not
known.
An interesting possibility is that the late steps in
a-factor processing are coupled to transport by Ste6p.
Coupled pathways have previously been proposed for
w xthe CaaX box processing enzymes 15,46 , as well as
w xfor pro-a-factor proteolysis and secretion 47 . A
similar coupling has been proposed between proteol-
ysis of cytosolic proteins and transport of their result-
ing peptides into the endoplasmic reticulum by the
ABC transporters, TAP1 and TAP2, during class I
w xantigen presentation 48,49 . Class I peptide antigens
are proteolytically processed by a multisubunit, mul-
w xticatalytic protease complex 50 . The substrate speci-
ficity of this complex partially determines which
w xpeptides are transported by the TAP proteins 51,52 .
TAP and Ste6p transporters are similar in many
ways. Both a-factor secretion and class I antigen
presentation require these transporters to deliver pro-
teolytically generated peptide signaling molecules to
the extracellular space. In each case, these signaling
peptides are used to identify cells of the same or
‘self’ species to mediate cell-cell contact, i.e. yeast
conjugation or T-cell receptor interaction. Yeast a-
factor secretion and mating may be a useful model
for mammalian class I antigen processing and pre-
sentation.
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